CSAGE, or Capture Selective Amplify and Gate, is a cutting-edge molecular biology technique designed to selectively target and analyze specific RNA transcripts from a complex mixture of RNA molecules. This method is particularly useful in transcriptomics, where it aids in the study of gene expression and regulation.The CSAGE technique involves several key steps. First, it uses molecular "capture" probes that are designed to specifically bind to the RNA transcripts of interest. These probes are typically short, complementary DNA or RNA sequences tailored to match the target RNA. Once bound, these probes allow for the selective isolation of the desired RNA from a complex sample, such as a cell or tissue extract.
Following capture, the targeted RNA undergoes an amplification process. This step is crucial because it increases the quantity of the RNA of interest, making it more detectable and analyzable. Amplification is typically achieved through techniques like PCR (Polymerase Chain Reaction), which can efficiently replicate specific RNA sequences.The final step, "gate," refers to the analysis and quantification of the amplified RNA. This can be done through various methods, such as sequencing or hybridization-based approaches. The data obtained provide insights into the abundance and variants of the targeted RNA transcripts, offering valuable information about gene expression patterns and regulation mechanisms. CSAGE is particularly advantageous in scenarios where precise and selective analysis of specific RNA molecules is required. It is used in research areas like cancer biology, developmental biology, and neuroscience, helping scientists understand complex gene expression dynamics in health and disease.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibiteur de l'ADN méthyltransférase, la 5-Azacytidine peut réactiver des gènes réduits au silence dans les cellules cancéreuses, ce qui peut affecter l'expression ou l'activité du CSAGE. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
La trichostatine A, un inhibiteur de l'histone désacétylase, modifie la structure de la chromatine et peut influencer indirectement l'expression du CSAGE. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Comme la trichostatine A, le vorinostat est un inhibiteur de l'histone désacétylase qui pourrait indirectement affecter le CSAGE en modifiant l'expression des gènes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Le cisplatine, un médicament chimiothérapeutique, induit des dommages à l'ADN, ce qui pourrait indirectement influencer l'expression ou l'activité du CSAGE dans les cellules cancéreuses. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
La doxorubicine, un antibiotique anthracycline utilisé dans la chimiothérapie du cancer, pourrait affecter les cellules exprimant le CSAGE en induisant des dommages à l'ADN et l'apoptose. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibiteur de mTOR, la rapamycine peut moduler la croissance et la prolifération cellulaires, affectant potentiellement la fonction CSAGE dans les cellules cancéreuses. | ||||||